Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jenny Seligmann"'
Autor:
Louise C Brown, David Fisher, Richard Adams, Jenny Seligmann, Matthew Seymour, Richard Kaplan, Susan D Richman, Philip Quirke, Rachel Butler, Helen Roberts, Janet Graham, Richard H Wilson, Timothy S Maughan
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 9, Iss 9 (2022)
Background: Complex trials with innovative designs are becoming increasingly common and offer the potential to improve patient outcomes in a shorter time frame. There is evidence that patients with colorectal cancer fall into different subgroups with
Externí odkaz:
https://doaj.org/article/a710ce8c7ebb4534b2145ccccfea160e
Autor:
Nicholas West, Sarah Brown, Alexandra Smith, Mark Saunders, Amanda Webster, David Sebag-Montefiore, Mark Teo, Simon Gollins, Jenny Seligmann, Simon P Bach, Monica Jefford, Alexandra Gilbert, Eleanor M Hudson, Samantha Noutch, Ravi Adapala, Carole Burnett, Alwyn Burrage, Maria Hawkins, Debra Howard, Rohit Kochhar, Edward JD Webb, Ane L Appelt
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Introduction The standard of care for patients with localised rectal cancer is radical surgery, often combined with preoperative neoadjuvant (chemo)radiotherapy. While oncologically effective, this treatment strategy is associated with operative mort
Externí odkaz:
https://doaj.org/article/5076921d830b40879b4eaba34fff4948
Autor:
James R. Platt, Christopher J. M. Williams, Zoe Craig, David A. Cairns, James C. Glasbey, Dion Morton, Jenny Seligmann
Publikováno v:
Colorectal Disease. 25:357-366
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f48eef71d7a3b77f9d8436aef250251
https://doi.org/10.1111/codi.16487
https://doi.org/10.1111/codi.16487
Autor:
Pierre Laurent-Puig, Marc Peeters, Jenny Seligmann, Peter Burdon, Julien Taieb, Andrea Sartore-Bianchi, Andreas Jung, Clara Montagut, Aziz Zaanan
Publikováno v:
Drugs
The approval of targeted therapies for metastatic colorectal cancer (mCRC) has led to important improvements in patient outcomes. However, it is still necessary to increase individualisation of treatments based on tumour genetic profiles to optimise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee72f8392e082e73a4c1aea5ceaeb1d
https://pubmed.ncbi.nlm.nih.gov/31347092
https://pubmed.ncbi.nlm.nih.gov/31347092
Autor:
Richard, Adams, Ewan, Brown, Louise, Brown, Rachel, Butler, Stephen, Falk, David, Fisher, Richard, Kaplan, Phil, Quirke, Susan, Richman, Leslie, Samuel, Jenny, Seligmann, Matt, Seymour, Kai Keen, Shiu, Harpreet, Wasan, Richard, Wilson, Tim, Maughan
Publikováno v:
The lancet. Gastroenterologyhepatology. 3(3)
A substantial change in trial methodology for solid tumours has taken place, in response to increased understanding of cancer biology. FOCUS4 is a phase 2-3 trial programme testing targeted agents in patients with advanced colorectal cancer in molecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f545c60faf7b3fb5dbd5db26b0e9bb9d
https://pubmed.ncbi.nlm.nih.gov/29254888
https://pubmed.ncbi.nlm.nih.gov/29254888
Publikováno v:
Journal of Clinical Pathology; Jul2012, Vol. 65 Issue 7, p580-584, 5p